Periodic reanalysis of whole-genome sequencing data enhances the diagnostic advantage over standard clinical genetic testing.

Eur J Hum Genet 2018 05 16;26(5):740-744. Epub 2018 Feb 16.

Genome Diagnostics, Department of Paediatric Laboratory Medicine, The Hospital for Sick Children, Toronto, ON, Canada.

Whole-genome sequencing (WGS) as a first-tier diagnostic test could transform medical genetic assessments, but there are limited data regarding its clinical use. We previously showed that WGS could feasibly be deployed as a single molecular test capable of a higher diagnostic rate than current practices, in a prospectively recruited cohort of 100 children meeting criteria for chromosomal microarray analysis. In this study, we report on the added diagnostic yield with re-annotation and reanalysis of these WGS data ~2 years later. Explanatory variants have been discovered in seven (10.9%) of 64 previously undiagnosed cases, in emerging disease genes like HMGA2. No new genetic diagnoses were made by any other method in the interval period as part of ongoing clinical care. The results increase the cumulative diagnostic yield of WGS in the study cohort to 41%. This represents a greater than 5-fold increase over the chromosomal microarrays, and a greater than 3-fold increase over all the clinical genetic testing ordered in practice. These findings highlight periodic reanalysis as yet another advantage of genomic sequencing in heterogeneous disorders. We recommend reanalysis of an individual's genome-wide sequencing data every 1-2 years until diagnosis, or sooner if their phenotype evolves.

Download full-text PDF

Source
http://www.nature.com/articles/s41431-018-0114-6
Publisher Site
http://dx.doi.org/10.1038/s41431-018-0114-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5945683PMC
May 2018
43 Reads

Publication Analysis

Top Keywords

sequencing data
8
clinical genetic
8
genetic testing
8
whole-genome sequencing
8
periodic reanalysis
8
diagnostic yield
8
diagnostic
5
chromosomal microarray
4
greater 5-fold
4
represents greater
4
5-fold increase
4
criteria chromosomal
4
41% represents
4
cohort 41%
4
report diagnostic
4
study report
4
analysis study
4
microarray analysis
4
children meeting
4
3-fold increase
4

References

(Supplied by CrossRef)

DJ Stavropoulos et al.
NPJ Genom Med 2016

Anath C Lionel et al.
Genetics in Medicine 2017

C Gilissen et al.
Nature 2014

JC Taylor et al.
Nat Genet 2015

LK Willig et al.
Lancet Respir Med 2015

G Costain et al.
Am J Med Genet A 2017

AM Wenger et al.
Genet Med 2017

AC Need et al.
J Med Genet 2017

SL Sawyer et al.
Clin Genet 2016

TY Tan et al.
JAMA Pediatr 2017

MJ Landrum et al.
Nucleic Acids Res 2016

Similar Publications